Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biomarkers for Invasive Mucormycosis
Sponsor: University Hospital, Lille
Summary
Mucormycosis (MM) is one of the main invasive fungal infection (IFI), and is determined by filamentous fungi belonging to the order of Mucorales, with a mortality rate ranging from 20 to 60% according to localization. Prompt initiation of adequate antifungal therapy is critical for treating mucormycosis. Early diagnostic is therefore essential. The presence in the Mucorales' cell wall of uncommon monosaccharides open interesting perspectives for the development of specific diagnostic biomarkers. This study evaluate a diagnostic test for mucormycosis in a cohort of patients with MM and in control groups (high-risk patients without MM and patients with another IFI).
Official title: Diagnostic Marker of Mucormycosis : Development and Evaluation of a Diagnostic Assay on a Cohort of Sera
Key Details
Gender
All
Age Range
3 Years - 64 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2023-11-29
Completion Date
2026-07
Last Updated
2025-12-26
Healthy Volunteers
Yes
Conditions
Interventions
Venous sample
at Day 0, Day 3, Day 7, Day 14, Day 28 (7 ml blood sample collecting on dry tube) D0 = Diagnostic day
Locations (1)
University Hospital of Lille
Lille, Hauts-de-France, France